Nicolaus Kröger, MD, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, describes haploidentical donors and discusses to what extent they are a suitable choice for transplant. This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.
Speaker: Nicolaus Kröger,Event: COSTEM 2019,Format: Interview,Subject: Leukemia,Field: Transplantation,Field: Treatment,MUD,HLA,disparity,GVHD,Medicines: Cyclophosphomide,
Nicolaus Kröger, MD, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, describes haploidentical donors and discusses to what extent they are a suitable choice for transplant. This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.
0 Comments